Cargando…
Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats
Xylazine is a potent analgesic extensively used in veterinary and animal experimentation. Evidence exists that the analgesic effect can be inhibited using adenosine 5’-monophosphate activated protein kinase (AMPK) inhibitors. Considering this idea, the aim of this study was to investigate whether th...
Autores principales: | Shi, Xing-Xing, Yin, Bai-Shuang, Yang, Peng, Chen, Hao, Li, Xin, Su, Li-Xue, Fan, Hong-Gang, Wang, Hong-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822969/ https://www.ncbi.nlm.nih.gov/pubmed/27049320 http://dx.doi.org/10.1371/journal.pone.0153169 |
Ejemplares similares
-
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016) -
Roles of adenosine monophosphate-activated protein kinase (AMPK) in the kidney
por: Zhu, Na, et al.
Publicado: (2022) -
Effects of dietary energy level on appetite and central adenosine monophosphate-activated protein kinase (AMPK) in broilers
por: Hu, Xiyi, et al.
Publicado: (2019) -
Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes
por: Ha, Tae-Sun, et al.
Publicado: (2014) -
Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
por: Hajra, A, et al.
Publicado: (2017)